Novo Nordisk has officially launched Ozempic in India, marking a significant expansion of its presence in one of the world’s fastest-growing markets for diabetes and obesity treatments. The launch comes at a time when demand for weight-loss drugs is rising sharply, driven by lifestyle changes, urbanisation, and increasing awareness of…
Canopy Growth stock price staged a strong comeback in the pre-market session as investors cheered the latest news on…
In Venezuela, money does not enter the economy as a steady stream. Instead, it arrives in bursts, timed to…
Broadcom stock price suffered a 5% reversal on Friday, a day after the company published strong financial results, and…
BBVA is moving artificial intelligence from limited trials into everyday banking work by extending access to ChatGPT across almost…
Russian seaborne oil product exports dipped slightly in November, falling 0.8% from October to 7.494 million metric tons, according…
Google DeepMind is sharpening its scientific ambitions with a new automated research lab in the UK, signalling a broader…